The efficacy and safety of PAD and VAD regimens for untreated multiple myeloma

Zhonghua nei ke za zhi [Chinese journal of internal medicine]

Volumn 49, Issue 9, 2010, Pages 762-764

  Zhao, Y ^a   Dou, Li ping ^b   Wang, Shu hong ^b   Bo, Jian ^b   Wang, Quan shun ^b   Huang, Wen rong ^b   Jing, Y ^b   Gao, Chun ji ^b   Li, Hong hua ^b   Zhu, Hai yan ^b   Han, Xiao ping ^b   Yu, L ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; BORTEZOMIB; DEXAMETHASONE; DOXORUBICIN; PYRAZINE DERIVATIVE; VINCRISTINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; DEXAMETHASONE; DOXORUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PYRAZINES; TREATMENT OUTCOME; VINCRISTINE;

EID: 84879790160     PISSN: 05781426     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)